Skip to main content

Table 4 Correlations of PWv with clinical variables and cardiovascular risk factors in relation to TOAST stroke subtype

From: Immune-inflammatory markers and arterial stiffness indexes in subjects with acute ischemic stroke with and without metabolic syndrome

 

Lacunar

 

LAAS

 

CEI

 

Variable

Pulse wave velocity (PWv)

 

Pulse wave velocity (PWv)

 

Pulse wave velocity (PWv)

With metabolic syndrome (n: 49)

Without metabolic syndrome (n 52)

P

With metabolic syndrome (n: 45)

Without metabolic syndrome (n: 37)

P

With metabolic syndrome (n:32)

Without metabolic syndrome (n:35)

P

CRP

0.32

0.27

0.031

0.38

0.32

0.041

0.29

0.28

0.63

IL-1-β

0.34

0.29

0.029

0.37

0.29

<0.05

0.31

0.28

0.75

IL-6

0.33

0.28

0.030

0.35

0.32

0.041

0.29

0.28

0.63

TNF-α

0.32

0.27

0.028

0.31

0.29

<0.05

0.31

0.28

0.75

E-selectin

0.32

0.23

0.65

0.31

0.23

0.041

0.19

0.20

0.61

P-selectin

0.34

0.27

0.071

0.29

0.24

<0.05

0.17

0.21

0.37

VICAM-1

0.33

0.29

0.060

0.36

0.26

0.041

0.19

0.20

0.61

ICAM-1

0.34

0.26

0.072

0.38

0.33

0.041

0.17

0.21

0.37

IL-10

0.20

0.22

0.56

0.21

0.23

0.66

0.23

0.25

0.57

vWF

0.37

0.31

0.023

0.41

0.34

<0.05

0.40

0.31

<0.05

PAI-1

0.31

0.22

0.043

0.34

0.23

0.041

0.19

0.20

0.61

TPA

0.29

0.26

0.55

0.26

0.24

0.75

0.20

0.21

0.37

  1. Coefficients (r) and p-values are calculated by the Pearson correlation mode.
  2. SBP: systolic blood pressure; DBP: diastolic blood pressure; MAP: mean arterial pressure; AIx: augmentation index; PWV: pulse wave velocity; SSS: Scandinavian Stroke Scale score; NIHSS: National Institutes of Health Stroke Scale; Angiotensin II receptor blockers (ARBs); CAD: coronary artery disease; CHF: congestive heart failure; LVH: left ventricular hypertrophy; WMHLS: white matter hypertension lesions.
  3. Demographic and history data are expressed as n° (percentage).
  4. Significant R and p are in bold.